Cargando…
HER2 Gene Amplification Testing by Fluorescent In Situ Hybridization (FISH): Comparison of the ASCO-College of American Pathologists Guidelines With FISH Scores Used for Enrollment in Breast Cancer International Research Group Clinical Trials
PURPOSE: ASCO and the College of American Pathologists (ASCO-CAP) recently recommended further changes to the evaluation of human epidermal growth factor receptor 2 gene (HER2) amplification by fluorescent in situ hybridization (FISH). We retrospectively assessed the impact of these new guidelines b...
Autores principales: | Press, Michael F., Sauter, Guido, Buyse, Marc, Fourmanoir, Hélène, Quinaux, Emmanuel, Tsao-Wei, Denice D., Eiermann, Wolfgang, Robert, Nicholas, Pienkowski, Tadeusz, Crown, John, Martin, Miguel, Valero, Vicente, Mackey, John R., Bee, Valerie, Ma, Yanling, Villalobos, Ivonne, Campeau, Anaamika, Mirlacher, Martina, Lindsay, Mary-Ann, Slamon, Dennis J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5074347/ https://www.ncbi.nlm.nih.gov/pubmed/27573653 http://dx.doi.org/10.1200/JCO.2016.66.6693 |
Ejemplares similares
-
Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines
por: Press, Michael F., et al.
Publicado: (2018) -
Validity of 1% Hormonal Receptor Positivity Cutoff by the ASCO/College of American Pathologists Guidelines at the Georgia Cancer Center
por: Kreidieh, Firas, et al.
Publicado: (2022) -
Characteristics of HER2-negative breast cancers with FISH-equivocal status according to 2018 ASCO/CAP guideline
por: Kong, Hui, et al.
Publicado: (2022) -
Integrating a FISH imaging system into the cytology laboratory
por: Smith, G. Denice, et al.
Publicado: (2010) -
ASCO update on lymphoma
por: Fridrik, Michael A.
Publicado: (2017)